HC Wainwright Adjusts Price Target on ANI Pharmaceuticals to $53 From $50, Keeps Buy Rating
7:34AM ET 3/13/2023 MT NewswiresANI Pharmaceuticals (ANIP) has an average rating of outperform and price targets ranging from $40 to $55, according to analysts polled by Capital IQ. (MT...